Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
If you all notice, the "bad guys" never pick on the science......
Black, I agree with you, and as I am not generally a conspiracy theorist, I have believed for a while now that these unprecedented ongoing attacks are part of a BP effort to keep the pps beat down as much as possible to stage for a lower priced buyout attempt.
Bill, I agree, and wasn't concerned with safety based on history of over 900 patients to date (including HIV studies)
Om, very good point. There is no way that the DSMC would have had time to properly evaluate the efficacy, just the safety versus the placebo.
I never said that he was on any board, just that he agreed the logic of my thinking. I was unaware that he was a shareholder, and have never heard that.
In a nut shell, I just reiterated EUA efficacy results data, and asked if my thinking was on track to assume the same results in Serious/Critical if also seen by DSMB if they would stop trial, and for "humanitarian" reasons grant EUA. His response was, "yes, you are thinking the right way."
Nurse, that is what I expect......BP is also on board with that possibility, via personal correspondence...
Perhaps DSMB meeting went well? BIG SURPRISE. Efficacy should be consistent with EUA patients...
How 'bout "them" charts?????? ??????????????
No press release. Not required. Just his extremely educated opinion. Back to playing in Cancun.....nothing has changed here....LOL
Gasman, Excellent work!!!!
Evil, exactly!!!! For once, Nader needs to under promise & over deliver!!!! THAT would be fun!!!
Big, do you. or does anyone else know, offhand, what other monoclonal drugs would be wrapping up studies now?
I am with 'ya, Blue...
AF is losing his punch. Perhaps he has finally cried wolf one time too many!!!!
Right on time, as expected....
I am more immediately interested in what the DSMB has to say next week. If Leronlimab has the same efficacy as seen in EUI patients, THAT could be a game changer......
Excellent
I just don't want those who are scrutinizing most closely to have more ammo. Look at the last promise....."Next Tuesday (NP said 2 weeks ago on a Thurs.or Fri.) the world will know this great data.....national press conference." The pps paid for that unkept promise
There are MANY more potential indications than CV. CV is just a starter (actually HIV was supposed to be)
Daemon57, I am on your side, but he actually said "10 days or so." We have had plenty of missed "deadlines." Let's not set us up for any more bashing than we need to.
hite, nice job, thank you
What is up with these people asking questions? Gosh!!!
"10 days, or so"
Reports state that Herman Cain dies from CV. The FDA needs to get off of their ........
complete garbage!
Do you really think that a commercial lender would lend money, under those terms, without having a good sense of the quality of trial data? Without good trial data the ability to generate revenues to repay the loan doesn't exist. Look at the terms and tell me that the lender isn't comfortable with the risk. Do you realky think that Nader isn't sharing information? If you think that you need to come into the REAL world.
The shorts are squirming......
Obviously, you have not been paying attention. This money was needed for Uplisting, which was the original reasoning given for increasing the A.S. That's why it says in the p.r. that they won't need to tap that at this time. We already knew they needed funds to do this, they just figured a different way to skin a cat.
No, it is not high, for what it is financing. We are not financing residential real estate pegged at the current 10 year treasury with 745+ FICO score, and 20% down.....
What don't you like about it? Would you rather them dilute by 6 million shares? The interest rate? What do you expect it to be for a loan to a pre- revenue, OTC biotech? The fact that they agreed to a $10 convertible price is encouraging, and awesome.....again for a pre-revenue, OTC biotech
Did the charts predict this, or was it built into what they were " telling us?"
LOL
Trend, I agree. FOMO!!!!
Evil, my sentiments 100%!!! Cheers!!!
Smiley, I agree with you there. At the end of the day the science and data (significant news) will dictate the pps. In the mean time, the shorts shake loose hands by instilling fear into the minds of the weak and uneducated (many are gambling with the rent money and are skittish as they can't afford to lose). I re-watched a video yesterday with Dr. Yo, Dr. Mike, and BP where Dr. Mike asked both Dr. Yo and BP if they contracted CV if Leronlimab would be their go-to drug, of any on the planet. Both stated "yes" emphatically, and Dr. Yo went so far as having already discussed with his parents and rest of family how to get a hold of Dr. P in the event that he contracted. It's all about the science, at the end of the day.....
Clam, I am with you 100%. As I have said many times, I bought this stock for 1 reason, and 1 reason only....the asset Leronlimab. I don't care about the CEO's history, or the company's history, for that matter. The value lies in the asset Leronlimab, period.
but he did....
Gosh, that crept up on me.....As I already digested that concept, I actually forgot that was tomorrow. TY
Scooter, is there a CC tomorrow?
Dr. Otto Yang, at UCLA, is our link there.